Your browser doesn't support javascript.
loading
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
Khalil, Eltahir A G; Weldegebreal, Teklu; Younis, Brima M; Omollo, Raymond; Musa, Ahmed M; Hailu, Workagegnehu; Abuzaid, Abuzaid A; Dorlo, Thomas P C; Hurissa, Zewdu; Yifru, Sisay; Haleke, William; Smith, Peter G; Ellis, Sally; Balasegaram, Manica; EL-Hassan, Ahmed M; Schoone, Gerard J; Wasunna, Monique; Kimutai, Robert; Edwards, Tansy; Hailu, Asrat.
Afiliação
  • Khalil EA; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Weldegebreal T; Arba Minch Hospital, Regional Health Bureau of SNNP State, Arba Minch, Ethiopia.
  • Younis BM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Omollo R; Drugs for Neglected Diseases initiative (DNDi) Africa Regional Office, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Musa AM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Hailu W; University of Gondar, College of Medicine & Health Sciences, Gondar, Ethiopia.
  • Abuzaid AA; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Dorlo TP; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands ; Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hurissa Z; University of Gondar, College of Medicine & Health Sciences, Gondar, Ethiopia.
  • Yifru S; University of Gondar, College of Medicine & Health Sciences, Gondar, Ethiopia.
  • Haleke W; Arba Minch Hospital, Regional Health Bureau of SNNP State, Arba Minch, Ethiopia.
  • Smith PG; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Ellis S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • Balasegaram M; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.
  • EL-Hassan AM; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
  • Schoone GJ; Royal Tropical Institute, KIT Biomedical Research, Amsterdam, The Netherlands.
  • Wasunna M; Drugs for Neglected Diseases initiative (DNDi) Africa Regional Office, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya ; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Kimutai R; Drugs for Neglected Diseases initiative (DNDi) Africa Regional Office, Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya ; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Edwards T; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Hailu A; School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
PLoS Negl Trop Dis ; 8(1): e2613, 2014.
Article em En | MEDLINE | ID: mdl-24454970
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anfotericina B / Leishmaniose Visceral / Antiprotozoários Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anfotericina B / Leishmaniose Visceral / Antiprotozoários Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2014 Tipo de documento: Article